The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted). Shingrix is indicated for the prevention of herpes ...

The Food and Drug Administration (FDA) has accepted for review the regulatory application for a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted). Shingrix is ...

The prefilled syringe presentation is licensed in the United States for immunization of adults 50 years and older, as well as those aged 18 years and older who are or will be at increased risk for ...

PHILADELPHIA, PA — GSK plc recently received approval from the U.S. Food and Drug Administration (FDA) for a prefilled syringe version of SHINGRIX, the company’s vaccine for shingles (herpes ...

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster vaccine for adult patients.

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster).